Large conductance voltage-and Ca
-activated potassium channels (BK channels) are important feedback regulators in excitable cells and are potently regulated by protein kinases. The present study reveals a dual role of protein kinase C (PKC) on BK channel regulation. Phosphorylation of S 695 by PKC, located between the two regulators of K + conductance (RCK1/2) domains, inhibits BK channel open-state probability. This PKC-dependent inhibition depends on a preceding phosphorylation of S 1151 in the C terminus of the channel α-subunit. Phosphorylation of only one α-subunit at S 1151 and S 695 within the tetrameric pore is sufficient to inhibit BK channel activity. We further detected that protein phosphatase 1 is associated with the channel, constantly counteracting phosphorylation of S 695 . PKC phosphorylation at S 1151 also influences stimulation of BK channel activity by protein kinase G (PKG) and protein kinase A (PKA). Though the S 1151 A mutant channel is activated by PKA only, the phosphorylation of S 1151 by PKC renders the channel responsive to activation by PKG but prevents activation by PKA. Phosphorylation of S 695 by PKC or introducing a phosphomimetic aspartate at this position (S 695 D) renders BK channels insensitive to the stimulatory effect of PKG or PKA. Therefore, our findings suggest a very dynamic regulation of the channel by the local PKC activity. It is shown that this complex regulation is not only effective in recombinant channels but also in native BK channels from tracheal smooth muscle. and membrane voltage. They are expressed in many tissues, and are particularly abundant in nerve and smooth muscle, where they play a key role as negative and positive feedback regulators of cell excitability by conducting repolarizing and hyperpolarizing outward currents, as has been impressively demonstrated in mice with targeted deletion of the pore-forming α-subunit (1) (2) (3) (4) (5) . Alternative splicing of premRNA and protein phoshorylation generates structural and functional diversity of BK channels. Several serine/ threonine kinases, such as the cAMP-(PKA)-and cGMPdependent protein kinase (PKG) and protein kinase C (PKC), potently regulate BK channel activity. Their phosphorylation sites at the pore-forming α-subunit are fully conserved in almost all mammalian alternative splice variants, and mutation of the PKA and PKG phosphorylation sites abolished the kinase effect on channel activity in heterologous expression systems (6-10). In smooth muscle, PKA and PKG predominantly activate BK channels by increasing the apparent voltage and Ca 2+ sensitivity of the channel, whereas PKC exerts opposite effects (11). Experimental evidence indicates that hormones and drugs that activate PKA or PKG contribute to smooth muscle relaxation by activation of BK channels. In contrast, activators of PKC seem to reinforce contraction by inhibiting BK channels as negative feedback regulators (12). Despite the potential physiological and pathophysiological relevance, the molecular mechanism of BK channel inhibition by PKC has remained elusive. This is surprising because numerous hormones, neurotransmitters, and drugs bind to G protein-coupled receptors, which signal through pathways leading to activation of PKC.
We show in this study that PKC inhibits the open-state probability of BK channel α-subunits. This inhibition depends on a sequential phosphorylation of two distinct serines in the C terminus of the channel protein. In addition, both PKC phosphorylation sites have important effects on the regulation of BK channels by PKA and PKG in primary cells, e.g., freshly isolated smooth muscle cells of the mouse trachea.
Results
Inhibition of BK Channel Activity by PKC. The PKC-dependent BK channel regulation was investigated with the pore-forming BK channel α-subunit (KCNMA1) cloned from bovine trachea (BK A , corresponding to the BK zero variant) (9). When inside-out membrane patches were superfused at the cytosolic side with 30 nM of the catalytically active fragment of PKC (PKC c ), a decrease of macroscopic currents was observed at all voltages tested (−100 to +100 mV; Fig. 1 A and B) . The current decline started 30 s after the application of PKC c and reached a stable level within 4-5 min. At +80 mV, PKC reduced membrane conductance (G m ) from 13.7 ± 0.7 to 5.9 ± 0.5 nS, i.e., by 57.2 ± 3.4% (n = 7). Reduced G max could not be reversed by increasing voltage or Ca
2+
. The inhibitory PKC effect was abolished when inside-out patches were concurrently superfused for at least 5 min with PKC c and 5 μM of the PKC pseudosubstrate inhibitor peptide PKC [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] (Fig. 1A) . Representative macroscopic BK currents before (Ctr) and after application of 30 nM PKC c are shown in Fig. 1B . To avoid effects on channel activity of the storage buffers in which the purified protein kinases were dissolved, freshly excised inside-out patches were superfused with control solutions containing the same amount of storage buffer as the solution with the respective kinase (SI Materials and Methods). Experiments carried out on inside-out patches with low channel density in the presence of symmetrically high potassium (140 mM) revealed that PKC decreased channel open probability, NP o , by shortening channel open time and prolonging the closed state of the channel (Fig. 1 C-E) . Channel open and closed times were well fitted by two exponentials, corresponding to a short (τ 1 ∼1 ms) and a longer duration (τ 2 ∼10 ms for open time and ∼20 ms for closed time). PKC affected only τ 2 ; it shortened the channel open time from 12.0 ± 5.3 to 7.0 ± 2.9 ms (n = 9) and prolonged the closed time from 23.9 ± 3.8 to 47.5 ± 4.7 ms (n = 7). The single-channel Author contributions: X.-B.Z., I.W., T.W., P.R., and M.K. designed research; X.-B.Z., I.W., E.U., U.S., and M.S. performed research; X.-B.Z., I.W., and P.R. analyzed data; and X.-B.Z., I.W., T.W., P.R., and M.K. wrote the paper.
conductance, the voltage dependence, and the calcium sensitivity of BK channels were not affected by PKC (Fig. S1 ). A, at which the PKC activator phorbol 12-myristate 13 acetate (PMA) had lost its inhibitory effect, the activation of PKC reduced I BK at all potentials by ∼50% ( Fig. 2A) . In contrast, the inactive phorbol ester analog 4α-PMA (100 nM) had no significant effect on BK channel currents. The positions of the critical residues Ser 695 and Ser 1151 and the respective flanking regions within the BK A isoform are shown in Fig. 2B .
PKC-Induced Inhibition
To examine whether the negative charge added by phosphorylation of Ser 695 and Ser 1151 is responsible for BK channel inhibition by PKC, we constructed mutants in which either serine was replaced by the negatively charged amino acid aspartate (S  695 D  and S   1151   D) . Surprisingly, the S 1151 D mutant did not significantly differ from the nonmutated BK channel with respect to membrane conductance, the half-maximal activating voltage (V 1/2 ) and inhibition of conductance by 30 nM PKC c (cf. Fig. 2C with Fig. 1A ). Introducing a negative charge at position 695 (S 695 D), however, resulted in channels with a strongly reduced membrane conductance resembling that of nonmutated BK channels in the presence of PKC (cf. Fig. 2D with Fig. 1A ). At +80 mV, the mean membrane conductance of the S 695 D mutant was 6.4 ± 0.5 nS (n = 6), which is 47.4 ± 2.1% of the conductance measured in the nonmutated BK channel at the same potential. The mutant was insensitive toward PKC; a V 1/2 of 47.9 ± 3.6 mV (n = 6) vs. 51.6 ± 4.6 mV in seven controls indicates that its voltage-dependent activation was unchanged. Nearly identical results as those shown in Fig. 2D D, its membrane conductance was strongly reduced with respect to the nonmutated BK channel (by 59.8 ± 3.9% at +80 mV; n = 8), and PKC was ineffective (Fig. 2E) . Taken together, these findings indicate that phosphorylation of Ser 1151 is constitutive (or unconditional) in nonmutated BK channels and a prerequisite for PKC-induced BK channel inhibition by phosphorylation of Ser 695 (conditional phosphorylation). The decrease of membrane conductance depends solely on a negative charge at the amino acid position 695.
Stoichiometry of BK Channel Phosphorylation by PKC. BK channel α-subunits are assembled as tetramers. To investigate the stoichiometry of BK channel tetramer phosphorylation by PKC, we employed a strategy that allowed us to determine electrophysiologically the subunit composition of each BK channel from the single-channel current amplitude by introducing a mutation to the tetraethylammonium (TEA)-sensitive site (10, 14, 15). Introducing the point mutation Y 347 V in the subunit pore (Fig. 3A) strongly reduces the sensitivity of BK channels expressed in outside-out patches to extracellular TEA (2 mM), whereas nonmutated channels (WT) were completely blocked ( Fig. 3 B and C) . The stoichiometry of mixtures of TEA-sensitive and TEA-insensitive α-subunits could thus be predicted from the single-channel current amplitude in the presence of 2 mM TEA ( Fig. 3 B V mutant or the heterotetrameric channels, resulted in a robust inhibition of NP o by ∼60% ( Fig. 3D ; note that the data shown here for the mutant S
695
A are nearly identical with those obtained from the S 1151 mutant and which are therefore omitted). For comparison, the PKC-induced inhibition of NP o in homotetrameric nonmutated BK channels (WT), and the lacking PKC effect in homotetrameric S 695 A mutants, is also shown, albeit in the absence of TEA. Taken together, the findings show that only one BK channel α-subunit within the tetramer needs to be phosphorylated for PKC-induced channel inhibition ( Fig. 3 D and E) .
PKC Modulates the Effects of PKA and PKG on BK Channels. We have shown earlier that the mutation of the tandem PKC motif in the C terminus to alanine (S 1151 A/S 1154 A) switches BK channel regulation from PKG to PKA (9). When we applied 300 nM PKG to the cytosolic face of excised inside-out membrane patches expressing the S 1151 D mutant, we observed a 26 mV shift to the left of the normalized conductance-voltage relation (V 1/2 before, 51.4 ± 4.2 mV, n = 12; V 1/2 after PKG 25.1 ± 4.4 mV; n = 6). Opposite to PKG, the catalytic subunit of PKA (300 nM) had no significant influence on the S 1151 D mutant (V 1/2 before 51.4 ± 4.2 mV, n = 12; V 1/2 after PKA 48.5 ± 3.8 mV; n = 6; Fig. 4A ). These findings resemble those obtained earlier with the nonmutated BK channel (9). Inside-out membrane patches expressing the S 1151 A mutant, however, proved insensitive to stimulation by PKG but were responsive to PKA. V 1/2 obtained from normalized conductancevoltage relations was 52.1 ± 5.1 mV before (control, n = 14) and 50.7 ± 5.8 mV after the application of PKG (n = 7; not significant). In contrast, PKA shifted V 1/2 by 29 mV from 52.1 ± 5.1 (n = 14) to 22.7 ± 4.2 mV (n = 7; Fig. 4E ; n = 8). Mutation of Ser 695 in alanine abolished the inhibitory PKC effect on BK channels but had no influence on the stimulatory effect of additionally applied PKG (Fig. S3) . Thus, BK channels in which Ser 695 is phosphorylated by PKC or contain a negatively charged amino acid at this position are no longer regulated by cyclic nucleotide-dependent protein kinases.
PKC-Dependent Inhibition of BK Channels in Tracheal Smooth Muscle
Cells. To verify that the regulation of BK channels described above occurs not only in a heterologous expression system but also under physiological conditions, we investigated the PKC-dependent regulation of BK channel activity in native cells. Recently, we showed that stimulation of muscarinic M 2 receptors by carbamylcholine (CCh) inhibits BK channels in isolated smooth muscle cells of the mouse trachea (TSMCs) by a dual mechanism involving PKC and G i βγ (12). When we elicited whole-cell outward currents (I out ) in freshly isolated TSMCs, addition of the specific BK channelblocking peptide iberiotoxin (300 nM) revealed that more than 90% of I out was conducted by BK channels (Fig. S4 ). The application of 10 μM CCh decreased within 5 min I out at all potentials by ∼50%. At 80 mV, current densities decreased from 129.9 ± 22.3 to 69.0 ± 8.3 pA pF −1 , i.e., by 46.3 ± 4.7% ( Fig. 5A ; n = 16). Additional application of the membrane permeant-specific activators of PKG (300 μM 8-pCPT-cGMP) or PKA (300 μM Sp-5,6-DCI-cBIMPS) for 10 min, produced no further significant change of I out (Fig. 5A) . In contrast, when the protein kinase activators were applied in the absence of CCh, only the PKG activator enhanced I out by 63.1 ± 5.2% at 80 mV (n = 6), whereas the PKA activator or the β-adrenoreceptor agonist isoproterenol (10 μM) were ineffective (Fig. 5B ). To demonstrate that the abolition of the PKG effect in the presence of CCh was due to activation of PKC, we superfused TSMCs for 5 min with the PKC inhibitor Ro 31-8220 (1 μM), which did not significantly affect I out . When 10 μM CCh was added thereafter, inhibition of I out was not completely prevented because G i βγ subunits partially inhibit BK channels (12). Further application of 300 μM 8-pCPT-cGMP, however, induced within 3-4 min an increase of BK channel activity by 66.0 ± 8.9% (n = 6), which is comparable to the increase obtained in control cells in the absence of CCh (cf. Fig. 5C with Fig. 5B ). Taken together, the findings clearly show that similar to recombinant BK channels, PKG but not PKA regulates BK channels in TSMCs, and that CCh via activation of PKC abolishes the kinase effect.
To provide supporting evidence, that dephosphorylation of a PKC-specific site, presumably Ser 1151 , switches the regulation of BK channels also in TSMCs from PKG to PKA, inside-out patches were superfused for 5 min with the inhibitory peptide PKC 19-31 . To allow complete dephosphorylation of PKC sites, inside-out patches were first superfused for 5 min with ATP-free solution to which 5 μM PKC 19-31 had been added. This solution, which did not significantly alter NP o , was then changed for another 5 min to a solution containing ATP, PKC 19-31 , and either PKG or PKA. Similar to the results obtained with the mutant BK channel S 1151 A (Fig. 4B) , PKC 19-31 prevented the stimulatory action of PKG in TSMCs and switched the responsiveness of the channel toward PKA. At a holding potential of 40 mV, NP o was not significantly changed by PKG (control NP o 0.44 ± 0.05; after PKG 0.37 ± 0.05, n = 6), whereas a 2.4-fold increase was induced by PKA (control NP o 0.47 ± 0.03; after PKA 1.19 ± 0.17, n = 6; Fig. 5D ).
Finally, we wondered whether the effect of CCh on BK channel activity can be mimicked by the inhibition of channel-associated protein phosphatases (16-18). When we superfused inside-out patches from TSMCs with 20 nM of the protein phosphatase 1 inhibitor peptide (PPI2) for 5 min, NP o decreased by ∼50% at all (Fig. 5E; n = 13 ). Additional application of 300 nM PKG or PKA for 5 min produced no further significant effect on NP o (Fig. 5E ). When the experiments were repeated in the presence of the PKC inhibitor Ro 31-8220, PPI2 did not inhibit NP o , and additional application of 300 nM PKG enhanced NP o 2.6-fold at 40 mV from 0.52 ± 0.06 to 1.34 ± 0.15 ( Fig. 5F ; n = 6). Preferential inhibition of protein phosphatase 2A by 3 nM ocadaic acid for 10 min failed to induce BK channel inhibition and did not abolish PKG-dependent activation of BK channels (Fig. S5) .
Discussion
The data reported in this study establish that inhibition of BK channels by PKC depends on the unconditional and conditional phosphorylation of the C-terminal serine residues 1151 and 695, respectively. The inhibition of BK channel conductance by PKC is due to a decrease of channel open probability without changing the unitary current amplitude. From the open-and closed-time histograms it is obvious that the inhibitory effect of PKC is mediated by altering both the opening and closing process to stabilize the nonconducting conformations of the channel. The voltage dependence and the Ca 2+ sensitivity of the BK channel were not affected by PKC. In addition, the phosphorylation of the BK channel by PKC abolishes the stimulatory effects of PKA and PKG.
We investigated the mechanism underlying the PKC-induced BK channel inhibition using a BK channel isoform that contains no inserts at the alternative splice sites, and has been identified in a variety of species, including man (19, 20 695 mutants clearly demonstrate that a PKC-like inhibition of the BK channel depends exclusively on a negatively charged amino acid at position 695. BK channel α-subunits expressing a 59-amino acid stress-regulated exon at splice site 2 (STREX-1) exhibit an additional PKA consensus motif at serine residue 3 within the STREX insert (8, 10). PKA inhibits NP o of STREX channels via phosphorylation of S3 STREX , probably by preventing palmitoylation of the C terminus (24). Interestingly, the S3 STREX is located within the RCK1 and RCK2 linker only a few amino acids upstream of Ser 695 . BK channels are assembled as tetramers of pore-forming α-subunits (14), each of which includes a PKC phosphorylation site. We found that phosphorylation of only one BK α-subunit either at Ser 1151 or Ser 695 is sufficient for channel inhibition. Thus, the PKC-dependent inhibition obeys a single subunit rule, which is similar to the inhibitory effect of PKA in STREX channels, but different from insertless BK channels where phosphorylation of all four α-subunits is required for channel activation by PKA (10). Whether prevention of palmitoylation of the C terminus also plays a role for PKC-dependent BK channel inhibition is presently unknown. Note, however, that the phosphorylation of S3 STREX by PKA produced a ∼20-mV rightward shift of the voltage-dependent activation curve (25), whereas PKC reduced the maximal BK channel activity without affecting the apparent voltage sensitivity. A similar observation has been made earlier with PKC on BK channels in pituitary CH 4 C 1 cells (26).
The unconditional and conditional phosphorylation of BK channels by PKC implies differential tasks in channel regulation. Besides the direct inhibition of channel activity, PKC phosphorylation apparently modulates PKA-and PKG-mediated effects. In accordance with previously published data (9, 27), the phosphorylation of Ser 1151 alone switches BK channel activation from PKA to PKG, whereas the additional phosphorylation of Ser 695 renders the BK channel completely insensitive to both cyclic nucleotidedependent kinases. Such a coregulation is not unique to BK channels but has also been observed in other ion channels. In T lymphocytes the modulation of delayed rectifier potassium channels by PKA is enhanced by PKC phosphorylation (28). Similarly, voltage-gated sodium channels require PKC phosphorylation to allow modulation by PKA (29).
The inhibition of BK channels by phorbol esters and PKC c has been shown before in isolated smooth muscle cells from different arterial beds (30, 31). In the present study, we used mouse TSMCs to prove that the regulation of BK channel activity by PKC in primary smooth muscle cells is identical to that observed in the recombinant channels. We chose TSMCs for two reasons. First, BK channels in mouse TSMCs represent the zero variant corresponding to the bovine trachea isoform. Second, the muscarinic receptor agonist CCh inhibits BK channels in TSMCs by activating the PKC via M 2 receptors (12). The data obtained in TSMCs are in complete accordance with the regulation observed with the recombinantly expressed BK channels. CCh decreased BK channel activity in TSMCs by ∼50% and abolished the stimulating effect of the PKG activator 8-pCPT-cGMP, which was effective in the absence of CCh. The broad-spectrum PKC inhibitor Ro-31-8220 inhibited the effects of CCh. Dephosphorylation of presumably Ser 1151 , by pretreating inside-out patches from TSMCs with ATP-free solution in the presence of the PKC pseudosubstrate inhibitor PKC 19-31 , resulted in a switch of channel regulation from PKG to PKA, resembling the switch in the S 1151 A mutant. The regulation of BK channels by closely associated phosphatases has been shown before (16-18). Therefore, the switch of channel regulation from PKG to PKA was likely due to the activity of a phosphatase that had dephosphorylated the channel at the PKC motif before the channel became responsive to PKA. Applying the selective protein phosphatase 1 peptide inhibitor PPI2 to inside-out patches of TSMCs resulted in a substantial decrease of NP o and prevented channel activation by either PKG or PKA. This effect was dependent on PKC, because Ro 31-8220 abolished the inhibitory effect of PPI2 and allowed PKG to enhance NP o . Inhibition of a protein phosphatase 2A by 3 nM ocadaic acid had no influence on BK channel activity. These findings, together with experiments performed in HEK293 cells expressing recombinant channels (Fig. S6) , provide strong evidence that BK channels are intimately associated with protein phosphatase 1 and PKC, and that interfering with the balance between kinase and opposing phosphatase activities can lead to the conditional phosphorylation of Ser 695 with the described consequences on channel regulation. The findings with PPI2 are intriguing because they disprove the concept of an indirect regulation of BK channels by protein kinases. It has been demonstrated that protein phosphatase inhibitors abolish or reverse the stimulatory effect of PKG (17) or of compounds that activate cGMP-dependent pathways, such as the natriuretic peptide ANP (32) or the β-amyloid-precursor protein β-APP (33), on BK channel activity. These observations had been taken as evidence that BK channels are stimulated by dephosphorylation of the channel protein due to the activation of an associated protein phosphatase. In light of the present findings, however, it is very likely that protein phosphatase inhibitors in TSMCs lead to the phosphorylation of Ser 695 by an endogenous PKC, which inhibits BK channels and renders them insensitive to cyclic nucleotide-dependent protein kinases.
In summary, we have shown that PKC via unconditional and conditional phosphorylation of the BK channel not only decreases channel open probability but also determines the regulation of the channel by other protein kinases such as PKG and PKA. By inhibiting BK channel activity and blunting the activating effects of PKG and PKA in TSMCs, PKC facilitates contraction and prevents relaxation via NO/cGMP-or cAMP-dependent pathways. The balance between phosphorylation by PKC and dephosphorylation by phosphatase 1 may vary in different cell types and may therefore explain the divergent results reported in the literature on BK channel regulation by PKG and PKA.
Materials and Methods
HEK293 cells were cultured for 24 h and then transiently transfected with the pcDNA3 plasmid containing the BK channel α-subunit BK A cloned from a bovine tracheal smooth muscle oligo dT-primed cDNA library (9) or with plasmids encoding the respective BK A mutant. The GenBank accession numbers for the BK channel isoform are AAK54352.1 (protein) and AY033472 (mRNA; BK A ). Tracheal smooth muscle cells were isolated as described previously (12). Standard patch-clamp recording techniques were used to measure currents in the whole-cell, outside-out, or inside-out patch-clamp configuration. The membrane conductance (G m ) was calculated as G m = I/(E m − E rev ), where I is macroscopic current, E m is the test membrane potential, and E rev is the reversal potential for potassium. Cell Culture and Transfection Procedure. HEK293 cells were cultured in minimum essential medium supplemented with Earle's salts medium (Biochrom) containing 10% FCS, 2 mM L-glutamine, 100 units mL −1 penicillin, 100 μg mL −1 streptomycin at 37°C, and 6% CO 2 . For transfection, 10 5 cells were plated in a 35-mm dish and cultured for another 24 h. Thereafter, the HEK293 cells were transiently cotransfected with EGFP (Clontech), cloned into the pcDNA3 vector (Invitrogen), and the pcDNA3 plasmid containing either the BK channel α-subunit BK A cloned from a bovine tracheal smooth muscle oligo dT-primed cDNA library (2), or the respective BK A mutant. The GenBank accession number for the BK channel isoform is AAK54352.1 (protein) and AY033472 (mRNA; BK A ). Transfection of 1 μg of each cDNA per dish was achieved by calcium phosphate precipitation for 18 h at 35°C and 3% CO 2 . After the medium was exchanged several times with PSS (see below), the cells were transferred in a 35-mm dish to the stage of an inverted microscope (Zeiss Axiovert 200) for electrophysiological measurements. The transfection efficiency varied between 50% and 70% as judged by the expression of EGFP in transfected cells. Cells with similar intensity of EGFP fluorescence were used for the experiments.
Site-Directed Mutagenesis. Mutant channels were generated by extended overlap PCR or a one-step PCR-based mutation protocol, a modified version of the QuikChange protocol (Invitrogen). PfuUltra DNA Polymerase (Stratagene) was used in the extended overlap PCR with the pcDNA3/BK A plasmid as template and the resulting amplicons were digested with suitable restriction enzymes and cloned back into the pcDNA3/ BK A background (2) . For the one-step PCR-based mutation protocol, the Phusion High-Fidelity DNA Polymerase (Finnzymes) was used for amplification of the whole pcDNA3/BK A plasmid. All mutations were confirmed by sequence analysis over the total length of amplification and the employed restriction sites.
Animals and Cell Preparation. All experimental procedures were carried out according to the animal welfare guidelines of the University Medical Center Hamburg-Eppendorf. C57BL/6 mice of either sex were obtained from a colony bred and maintained at the animal house of the University Medical Center HamburgEppendorf. Tracheae were dissected from mice killed by CO 2 . After the connective tissue was removed, the tissue was cut with a sharp blade into pieces of ∼1 mm side length and incubated under gentle agitation at 37°C in Ca 2+ -free PSS, including 0.7 mg mL
papain, 1 mg mL −1 1,4-dithio-D,L-threitol, and 1 mg mL −1 fat-free BSA. The tissue pieces were transferred 30 min later into PSS solution containing 50 μM Ca 2+ , 1 mg mL −1 collagenase, 1 mg mL −1 hyaluronidase, and 1 mg mL −1 albumin, and digested for another 8-10 min at 37°C. Single cells were released by gentle trituration of the digested tissue and stored in PSS at room temperature. After isolation, >50% of the cells were relaxed, and only these cells were used for the electrophysiological studies. The experiments were conducted within 6 h of cell isolation. A small aliquot of the solution containing the isolated cells was placed in an open perfusion chamber (1 mL) mounted on the stage of an inverted microscope (Zeiss Axiovert 200). The myocytes were allowed to adhere to the bottom of the chamber for 5-10 min and were then superfused at 2-3 mL min −1 with PSS at room temperature until the beginning of the experiment. 
where Po is the single-channel open-state probability, T is the duration of the measurement, t j is the time spent with j = 1,2.. N channels open, and N is the maximal number of simultaneous channel openings seen in the patch. NP o calculations were based on 15-s segments of single-channel recordings. The NP o averages of 12-20 segments (3-5 min), obtained immediately before and after the addition of a compound, were used for statistical analysis.
Open-and closed-time histograms were obtained from records with only one active channel. Estimation of the time constants was done according to Sigworth and Sine (4) by the maximum-likelihood method.
A holding potential of −10 mV was used in whole-cell patchclamp experiments and in inside-out patches when macroscopic currents were recorded. For the determination of NP o , the holding potential was +40 mV.
After establishment of the whole-cell, inside-out, or outsideout configurations, the cells or patches were superfused for 5-10 min with control solutions until the currents or channel activity became stable. If the current or channel activity was not stable after 10 min, the recording was terminated. For experiments with protein kinases, see below.
Solutions. For whole-cell experiments, the bath was superfused with PSS containing (in mM) 127 NaCl, 5.9 KCl, 2.4 CaCl 2 , 1.2 MgCl 2 , 11 glucose, and 10 Hepes adjusted to pH 7.4 with NaOH. The pipette solution contained (in mM) 126 KCl, 6 NaCl, 1.2 MgCl 2 , 5 EGTA, 11 glucose, 3 dipotassium ATP, 0.1 Na 3 GTP, and 10 Hepes adjusted to pH 7.4 with KOH. The free Ca 2+ concentration was adjusted to 0.3 μM by adding the appropriate amount of CaCl 2 as described previously (5) . Free Ca 2+ was checked by fura-2 fluorescence. For macroscopic current recordings in inside-out patches from HEK293 cells, the extracellular (pipette) solution is PSS. The bath solution (cytosolic surface of the patch) contained (in mM) 126 KCl, 6 NaCl, 1.2 MgCl 2 , 5 EGTA, 11 glucose, 3 dipotassium ATP, 0.1 Na 3 GTP, and 10 Hepes adjusted to pH 7.4 with KOH. The free Ca 2+ concentration was adjusted to 1 μM. For single-channel recordings in HEK293 and TSMC cells, the extracellular (pipette) solution is (in mM):132 KCl, 6 NaCl, 1.2 MgCl 2 , 5 EGTA, 11 glucose, 10 Hepes, pH 7.4 adjusted with KOH, and the bath solution (cytosolic surface of the patch) contained 126 KCl, 6 NaCl, 1.2 MgCl 2 , 5 EGTA, 11 glucose, 3 dipotassium ATP, 0.1 Na 3 GTP, and 10 Hepes, pH 7.4 adjusted with KOH. The free Ca 2+ concentration was 0.3 μM. For outside-out experiments, the same solutions as for single-channel recordings in inside-out experiments were used, except that the pipette and bath solutions were reversed. The free Ca 2+ concentration in the pipette was 0.3 μM.
The storage buffers for purified protein kinases were PKC: 100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 15 mM DTT, 10% glycerol, 20 mM Tris (pH 7.5); PKA (catalytic subunit): 50 mM NaCl, 1 mM EDTA, 10 mM 2-mercaptoethanol, 50% glycerol, 20 mM Tris (pH 7.5); PKG Iα: 10 mM TES, 1.25 mM DTT, 0.25 μg mL −1 leupeptine, 0.05% NaN 3 , 50% glycerol. When the effect of protein kinases was investigated in inside-out patches, appropriate amounts of storage buffers were diluted into the bath solution. To avoid significant effects of storage buffers on channel activity, patches were first superfused with storage buffer containing solutions alone until channel activity was stable (usually within 5-10 min), then superfusion with the same solution containing the respective protein kinase was started.
Statistical Analyses. SigmaPlot for windows (Jandel Scientific, version 11) was used for statistical analyses. Significance was determined by paired or unpaired t test or by one-way ANOVA. When a significant effect was detected with ANOVA, Student's t test was used for pairwise comparisons. The effects were deemed significant when a P < 0.05 was obtained. Results are expressed as means ± SE where applicable. A) has no influence on the PKG-dependent activation of BK channels in the presence of PKC. Inside-out patches were superfused with 30 nM PKC c first, and then additionally with either 300 nM PKG or PKA. Conductance-voltage relations were obtained by 300-ms depolarizing pulses every 5 s in 10-mV increments from −100 to +100 mV. Holding potential was −10 mV. Means ± SEM are shown. The respective V 1/2 values were 50.3 ± 4.8 (Ctr; n = 16), 48.7 ± 5.0 (PKC; n = 16), 46.8 ± 5.1 (PKC + PKA; n = 8), and 22.1 ± 3.0 mV (PKC + PKG; n = 8). The intracellular (bath) Ca 2+ concentration was 1 μM. The Ca 2+ concentration in the pipette was 0.3 μM. Fig. S5 . Inhibition of protein phosphatase 2A failed to inhibit BK channel activity and to abolish PKG-dependent activation. Inside-out patches from TSMCs were superfused at the cytosolic side with 3 nM ocadaic acid first (ok), and then additionally with 300 nM PKG. Means ± SEM of six patches from three mice at +40 mV are shown. **P < 0.01 vs. control (Ctr); ns, not significant. The intracellular (bath) Ca 2+ concentration was 0.3 μM. 
